McGuire E. Urodynamics of the neurogenic bladder. Urol Clin North Am. 2010;37(4):507–16.

Article  PubMed  Google Scholar 

Cheng PJ, Myers JB. Augmentation cystoplasty in the patient with neurogenic bladder. World J Urol. 2020;38(12):3035–46. A metanalysis looking at the indications and outcomes of augmentation cystoplasty in patients with neurogenic bladder.

Article  PubMed  Google Scholar 

Shreck E, Giola K, Lucioni A. Indications for augmentation cystoplasty in the year of onabotulinumtoxin A. Curr Urol Rep. 2016;17(27)

Schulte-Baukloh H, et al. Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urology. 2002;59(3):325–7.

Article  CAS  PubMed  Google Scholar 

Chancellor M, Smith C. Use of botulinum toxin in the genitourinary system. Handb Exp Pharmacol. 2021;263:171–84.

Article  CAS  PubMed  Google Scholar 

Welk B, Richardson K, Panicket J. The cognitive of anticholinergics for patients with overactive bladder. Nat RevUrol. 2021;18:686–700.

CAS  Google Scholar 

Ginsberg D, et al. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J Urology. 2012;187(6):2131–9.

Article  CAS  Google Scholar 

Cruz F, et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomized, double-blind, placebo-controlled trial. Euro Urol. 2011;60(4):742–50.

Article  CAS  Google Scholar 

Apostolidis A, Papeafstathiou E, Gatsos S, G. Intravesical botox for overactive bladder: how to minimize complications and manage failures. Curr Drug Targets. 2020;21(15):1527–2536.

Article  CAS  PubMed  Google Scholar 

Biers A, Venn S, Greenwell T. The past, present and future of augmentation cystoplasty. BJU International. 2012;109(9):1290–3.

Article  Google Scholar 

Trojan K, et al. Improvement of bladder function after bladder augmentation surgery: a report of 2 years of clinical experience. Pediatr Surg Int. 2022;38:41–948. A retrospective study looking at the long-term effects and quality of life after bladder augmentation in patients with spina bifida.

Article  Google Scholar 

Stein R, Schroider A, Thuroff J. Bladder augmentation and urinary diversion in patients with neurogenic bladder: non-surgical considerations. J Pediatr Urol. 2012;8(2):145–52.

Article  PubMed  Google Scholar 

Myeres J, et al. The effects of augmentation cystoplasty and botulinum toxin injection on patient-reported bladder function and quality of life among individuals with spinal cord injury performing clear intermittent catheterization. Neurourol Urodynamics. 2019;38(1):285–94.

Article  Google Scholar 

Chieh Lin C, Chorng Kuo C. Video-urodynamic characteristics and predictors of switching from botulinum neurotoxin a injection to augmentation enterocystoplasty in spinal cord injury patients. Toxins. 2022;14(1):47. A comparison of urodynamics parameters before and after receiving botox and augmentation cystoplasty in spinal cord injury patients.

Article  Google Scholar 

Toia B, et al. The efficacy of onabotulinumtoxinA in patients with previously failed augmentation cystoplasty: cohort series and literature review. Neurourol Urodyn. 2020;39(6):1831–6.

Article  CAS  PubMed  Google Scholar 

Michel F, et al. Botulinum toxin type a injection after failure of augmentation enterocystoplasty performed for neurogenic detrusor overactivity: preliminary results of a salvage strategy. The ENTEROTOX study. Urology. 2019;129:43–7.

Article  PubMed  Google Scholar 

Padmanabhan P, et al. Five-year cost analysis of intradetrusor injection of botulinum toxin type and augmentation cystoplasty for refractory neurogenic detrusor overactivity. World J Urology. 2010;29:51–7.

Article  Google Scholar 

Kim S, et al. Cost comparison of intradetrusor injection of botulinum toxin versus augmentation cystoplasty for refractory neurogenic detrusor overactivity in children. J Pediatr Urol. 2022;18(3):314–219.

Article  PubMed  Google Scholar 

Ginsberg DA, Boone TB, Cameron AP, et al. The AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction: treatment and follow-up. J Urolo. 2021;206:1106. The current guidelines on follow up management for neurogenic lower urinary tract dysfunction.

Article  Google Scholar 

Fendereski K, et al. Variation in provider practice patterns and the perceived need for a shared decision-making tool for neurogenic lower urinary tract dysfunction. Urology. 2023;174:185–90. A study looking at provider practice patterns when management neurogenic lower urinary tract dysfunction.

Article  PubMed  Google Scholar 

Ginsberg DA, Boone TB, Cameron AP, et al. The AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction: diagnosis and evaluation. J Urol. 2021;206:1097.

Article  PubMed  Google Scholar